Markets:

Overview

News

Currencies

International

Treasuries

Arvinas, Inc. - Common Stock (NQ:ARVN)

11.82 -0.77 (-6.08%)

Streaming Delayed Price Updated: 3:57 PM EST, Dec 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arvinas, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Looking Into Arvinas's Return On Invested Capital ↗

December 06, 2022

Via Benzinga

Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56% ↗

November 23, 2022

Mizuho cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $180. Mizuho analyst James Lee maintained the stock with a Buy rating. Baidu shares rose 2.5% to trade at $97.49 on Wednesday.

Via Benzinga

Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box ↗

November 23, 2022

Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to...

Via Benzinga

Analyst Ratings for Arvinas ↗

November 23, 2022

Via Benzinga

Where Arvinas Stands With Analysts ↗

November 23, 2022

Via Benzinga

Abercrombie & Fitch To Rally 21%? Plus This Analyst Predicts $237 For Autodesk ↗

November 23, 2022

Telsey Advisory Group raised the price target on Abercrombie & Fitch Co. (NYSE: ANF) from $25 to $27. Abercrombie & Fitch shares fell 1.2% to $22.34 in pre-market trading.

Via Benzinga

Where Arvinas Stands With Analysts ↗

September 09, 2022

Within the last quarter, Arvinas (NASDAQ:ARVN) has observed the following analyst ratings:

Via Benzinga

Expert Ratings for Arvinas ↗

September 09, 2022

Within the last quarter, Arvinas (NASDAQ:ARVN) has observed the following analyst ratings:

Via Benzinga

Recap: Arvinas Q2 Earnings ↗

August 04, 2022

Arvinas (NASDAQ:ARVN) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Arvinas's ARV-471 Achieves Clinical Benefit Rate Of 38% In Breast Cancer Setting ↗

November 22, 2022

Via Benzinga

Arvinas Announces ARV-471 Achieves a Clinical Benefit Rate of 38% in Evaluable Patients and Continues to Show a Favorable Tolerability Profile in its Phase 2 Expansion Trial (VERITAC)

November 22, 2022

From Arvinas Inc.

Via GlobeNewswire

Carvana, Crocs And Other Big Losers From Monday ↗

November 22, 2022

U.S. stocks closed lower on Monday, with the Nasdaq dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session ↗

November 21, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Arvinas Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 08, 2022

From Arvinas Inc.

Via GlobeNewswire

Arvinas to Present at Upcoming Conferences

November 01, 2022

From Arvinas Inc.

Via GlobeNewswire

Arvinas Announces Winner of the 2022 Arvinas Early Career Researcher Award

October 27, 2022

Katherine Donovan, Ph.D. of the Dana-Farber Cancer Institute has been awarded a $25,000 monetary prize recognizing her innovation in the field of targeted protein degradation

From Arvinas Inc.

Via GlobeNewswire

Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday ↗

October 27, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...

Via Benzinga

Wingstop, Harley-Davidson, Rollins And Some Other Big Stocks Moving Higher On Wednesday ↗

October 26, 2022

U.S. stocks traded mixed, with the Dow Jones gaining more than 200 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session ↗

October 26, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate...

Via Benzinga

Arvinas Appoints Paul McInulty as Senior Vice President, Regulatory Affairs

October 03, 2022

From Arvinas Inc.

Via GlobeNewswire

Arvinas Gives Back to Local Greater New Haven Community

September 30, 2022

From Arvinas Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗

September 09, 2022

Upgrades

Via Benzinga

Arvinas's Return on Invested Capital Insights ↗

August 22, 2022

According to Benzinga Pro data, Arvinas (NASDAQ:ARVN) reported Q2 sales of $31.30 million. Earnings fell to a loss of $70.00 million, resulting in a 10.41% decrease from last quarter.

Via Benzinga

Sanofi's Breast Cancer Drug Fallout 'Creates Buying Opportunity' For This Stock ↗

August 18, 2022

According to Oppenheimer analyst, the fallout of Sanofi SA's (NASDAQ: SNY) amcenestrant creates a buying opportunity for Arvinas Inc (NASDAQ: ARVN)

Via Benzinga

This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗

August 18, 2022

Gainers

Via Benzinga

Sanofi, Children's Place And Some Other Big Stocks Moving Lower On Wednesday ↗

August 17, 2022

Embark Technology, Inc. (NASDAQ: EMBK) fell 25.1% to $12.40. Embark Technology reported the completion of reverse stock split.

Via Benzinga

Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session ↗

August 17, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus...

Via Benzinga

8 Analysts Have This to Say About Arvinas ↗

August 08, 2022

Over the past 3 months, 8 analysts have published their opinion on Arvinas (NASDAQ:ARVN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names ↗

July 06, 2022

Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.